MK-677
prescription — get notified.
MK-677 (ibutamoren) is an orally active growth hormone secretagogue that stimulates the ghrelin receptor to increase endogenous GH and IGF-1 production — without injections. Enter your email to be notified if prescription access opens.
We'll email you if MK-677 prescription access opens. No spam.
What MK-677 actually is.
MK-677 is frequently mislabeled as a SARM. It is not. It is a non-peptide ghrelin receptor agonist that stimulates your body's own growth hormone production — orally, once daily, without injections.
Oral GH secretagogue
Unlike injectable growth hormone peptides (CJC-1295, GHRP-6, ipamorelin), MK-677 is taken as an oral capsule or tablet. It crosses the GI barrier intact and activates the ghrelin receptor (GHSR) to trigger pulsatile GH release from the pituitary — the same natural pattern as endogenous growth hormone secretion.
24-hour GH elevation
MK-677 has a half-life of approximately 4–6 hours, but its effect on GH pulsatility persists for a full 24 hours. A single daily dose produces sustained elevation of GH and IGF-1 levels without the supraphysiological peaks and troughs associated with exogenous HGH injection.
Extensive clinical data
MK-677 has been studied in multiple randomized controlled trials in humans — including studies on body composition, sleep quality, bone density, and nitrogen balance. Unlike many research compounds, ibutamoren has real human clinical trial data from peer-reviewed journals.
The oral alternative to growth hormone injections.
MK-677 stimulates your body's own GH production rather than replacing it with exogenous hormone. The trade-offs are different from injectable HGH.
| Feature | Injectable HGH | MK-677 (ibutamoren) |
|---|---|---|
| Administration | Daily subcutaneous injection | Oral — capsule or tablet |
| Mechanism | Exogenous GH replacement | Stimulates endogenous GH release via ghrelin receptor |
| GH pattern | Supraphysiological peak then clearance | Pulsatile (natural pattern) over 24 hours |
| IGF-1 increase | Significant, dose-dependent | Moderate, sustained |
| Prescription status | FDA-approved (limited indications) | Not FDA-approved — research compound |
| Monthly cost | $500–$3,000+ | $50–$150 (research / compounded) |
| Half-life | 2–3 hours (GH clearance) | 4–6 hours (effect lasts 24h) |
| Shutdown risk | Suppresses natural GH production | Stimulates natural production (no shutdown) |
Everything about MK-677 prescription.
Dosage and cycle protocol
Standard dosing, cycle length, half-life, timing, and why most protocols recommend 10–25 mg daily.
02 / 06Benefits and results
GH and IGF-1 elevation, body composition, sleep quality, recovery, bone density, and clinical trial outcomes.
03 / 06Side effects and safety
Water retention, appetite increase, insulin sensitivity, lethargy, numbness, and long-term safety data.
04 / 06Cost and pricing
Research compound pricing, compounding pharmacy estimates, MK-677 vs HGH cost comparison.
05 / 06MK-677 vs HGH
Detailed comparison with injectable growth hormone — mechanism, efficacy, sides, cost, and who benefits from each.
06 / 06Prescription FAQ
Regulatory status, is MK-677 a SARM, Category 2 classification, legal status, and prescription outlook.
Stay informed.
Enter your email to be notified if MK-677 prescription access opens.
We'll email you if MK-677 prescription access opens. No spam.